Nexus Conference, an enterprise committed to shaping events that act as powerful conduits between buyers and sellers, is proud to announce the Digital Health Nexus Conference that will be held in London on November 14-15, 2024. This event aims to bring together leaders from pharma/biotech, universities, VC/investors, hospitals, and service providers, with various topics in discussion, including AI and technology and digitization in biotech.
This event will feature at least 20 speakers, among them Ismael Gauci, the Senior Director, Strategy & Business Enablement – Digital Health & Precision Medicine at Roche; Dave Harden, the Founder and Managing Partner at Outpost Ventures; and Marco Palladino, the head of global…
To learn more, please visit https://ibn.fm/Hhpg8
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN